San Francisco
Ginger is a digital health company and developer of an app that provides members with access to unlimited self-guided care and 24/7 on-demand coaching, as well as video-based therapy and psychiatry support.
Estimated valuation today
$166M
-85.16% since last round
Calculated based on estimated multiplier and revenue.
Revenue
Update this based on your knowledge or projections. Calculations use last 12 months revenue.
Hype Multiple
Currently selected comps have a median growth rate of 11.40%
This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.
multiple
In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.
The last round was a year ago.
Date
March 2021
Valuation
$1.1B
Amount raised
$100M
We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.
Multiple at last round
1.66x revenue
Today's multiple
1.64x revenue
Change
-1.00%
Companies
Industry – Healthcare
Last updated 5 mins ago.
| Remove | Name | Ticker | Price multiple |
|---|---|---|---|
| Ginger | 1.64x | ||
| 1Life Healthcare Inc | ONEM | 4.38x | |
| HCA Holdings Inc | HCA | 1.04x | |
| Tenet Healthcare Corporation | THC | 0.37x | |
| Quest Diagnostics Incorporated | DGX | 1.51x | |
| Humana Inc | HUM | 0.67x |
| Date | Round | Amount raised | Price per share (Preferred) | Valuation |
|---|---|---|---|---|
| Mar 2021 | Series E | $100MM | $44.80 | $1.12B |
| Aug 2020 | Series D | $46.5MM | $9.46 | $202.15MM |
| Aug 2020 | Series D-1 | $5.06MM | $7.10 | $202.15MM |
| Sep 2019 | Series C | $29.94MM | $5.58 | $159.05MM |
| Aug 2019 | Series B-1 | $23.29MM | $6.71 | $41.74MM |
| Jan 2015 | Series B | $20.09MM | $34.38 | $52.05MM |
| Nov 2012 | Series A | $6.19MM | $21.74 | $18.69MM |
| Oct 2011 | Series Seed | $1.69MM | $10.10 | $5.07MM |
With a revenue of $68M and a Hype Multiple of 1.5x,
Ginger is estimated to be worth $166M.